MedTrace Logo

GISAR German Interdisciplinary Sarcoma Registry

NCT04122872 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 9000

Last updated 2026-02-05

No results posted yet for this study

Summary

GISAR has an open and modular setup. It is sought to include as many German sarcoma and CS patients (i.e. sarcoma and CS patients treated in Germany) in the registry as possible. A basic data set should be collected on every included patient). In order to adress specific scientific questions, additionally detailed data can be collected in defined patient groups (e.g. effectiveness / adverse effects of systemic therapies in defined situations) within the context of sub-project add-on modules. This data collection can be prospective or retrospective depending on the sub-project

Conditions

  • Sarcoma
  • Sarcoma,Soft Tissue
  • Sarcoma of Bone
  • Carcinosarcoma

Sponsors & Collaborators

  • Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

    lead OTHER

Principal Investigators

  • Salah-Eddin Al-Batran, Prof. Dr · Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-29
Primary Completion
2038-01-31
Completion
2038-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04122872 on ClinicalTrials.gov